The majority of elderly nursing home patients who undergo surgical or endovascular revascularization for lower-extremity PAD are unlikely to have improvements in function, and a high percentage will ...

Preoperative statins are associated with improved limb salvage after lower extremity revascularization, either endovascular or surgical. Patients who benefit most seem to be those with claudication, ...

For patients on clopidogrel (Plavix) when undergoing lower limb revascularization procedures, keeping it on board while adding rivaroxaban (Xarelto) and aspirin for preventing major adverse events ...

Lower extremity artery disease (LEAD) is a leading cause of morbidity and mortality worldwide, affecting hundreds of millions of people. On top of that, LEAD also represents a prominent marker of ...

Please provide your email address to receive an email when new articles are posted on . In a cohort of patients with renal impairment who underwent peripheral revascularization, rivaroxaban reduced ...

Please provide your email address to receive an email when new articles are posted on . Patients who underwent atherectomy during endovascular lower-extremity revascularization had lower rates of ...

CLEVELAND, OH — Postexercise ankle-brachial index (ABI) may be a useful predictor of CV outcomes in patients with peripheral artery disease (PAD), including those with a normal resting ABI, suggests ...

Compared with dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibitors were associated with lower risks of cardiac death and composite renal outcomes without ...

Rivaroxaban, in addition to low-dose aspirin, significantly reduced the occurrence of total severe events of the heart, limb or brain and issues related to other vascular complications in patients ...